Redox Modulation of Gi Protein Expression and Adenylyl Cyclase Signaling: Role of Nitric Oxide

Antioxidants and Redox Signaling

Volumn 6, Issue 2, 2004, Pages 385-392

  Anand Srivastava, Madhu B ^a   Di Fusco, Francesco ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CHOLERA TOXIN; FORSKOLIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN GI ALPHA2; PROTEIN GI ALPHA3; TAP WATER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; BLOOD VESSEL TONE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERTENSION; MALE; NONHUMAN; NORTHERN BLOTTING; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ADENYLATE CYCLASE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CHOLERA TOXIN; ENZYME INHIBITORS; FORSKOLIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HEART; MALE; MUSCARINIC AGONISTS; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXIDATION-REDUCTION; OXOTREMORINE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TISSUE EXTRACTS;

ANIMALIA;

EID: 1542724427     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308604322899459     Document Type: Review

References (54)

1. Anand-Srivastava MB. Altered responsiveness of adenylate cyclase to adenosine and other agents in the myocardial sarcolemma and aorta of spontaneously-hypertensive rats. Biochem Pharmacol 37: 3017-3022, 1988.
2. Anand-Srivastava MB. Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Relationship to adenylate cyclase inhibition. Biochem J 288: 79-85, 1992.
3. Anand-Srivastava MB. Platelets from spontaneously hypertensive rats exhibit decreased expression of inhibitory guanine nucleotide regulatory protein: relation with adenylyl cyclase activity. Circ Res 73: 1032-1039, 1993.
4. Anand-Srivastava MB. Downregulation of atrial natriuretic peptide ANP-C receptor is associated with alterations in G-protein expression in A-10 smooth muscle cells. Biochemistry 39: 6503-6513, 2000.
5. Anand-Srivastava MB, Srivastava AK, and Cantin M. Pertussis toxin attenuates atrial natriuretic factor-mediated inhibition of adenylate cyclase. Involvement of inhibitory guanine nucleotide regulatory protein. J Biol Chem 262: 4931-4934, 1987.
6. Anand-Srivastava MB, Picard S, and Thibault C. Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi alpha) in spontaneously hypertensive rats. Am J Hypertens 4: 840-843, 1991.
7. Anand-Srivastava MB, de Champlain J, and Thibault C. DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. Am JHypertens 6: 72-75, 1993.
8. Arnal JF, Elamrani AI, Chatellier G, Menard J, and Michel JB. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22: 380-387, 1993.
9. Bohm M, Gierschik P, Knorr A, Weismann K, and Erdmann E. Desensitization of adenylate cyclase and increase of Gi alpha in cardiac hypertrophy due to acquired hypertension. Hypertension 20: 103-112, 1992.
10. Bray P, Carter A, Simons C, Guo V, Puckett C, Kamholz J, Spiegel A, and Nirenberg M. Human cDNA clones for four species of G alphas signal transduction protein. Proc Natl Acad Sci USA 83: 8893-8897, 1986.
11. Cerione RA, Staniszewski C, Caron MG, Lefkowitz RJ, Codina J, and Birnbaumer L. A role for NO in the hormonal stimulation of adenylate cyclase. Nature 318: 293-295, 1985.
12. Chomczynski F and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
13. Feinberg AP and Vogelstein B. A technique for radiolabelling DNA restriction-endonuclease fragment to high specific activity. Anal Biochem 132: 6-13, 1983.
14. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, and Dop CV. Increase of the 40,000 mol wt pertussis toxin substrate (G-protein) in the failing human heart. J Clin Invest 82: 189-197, 1988.
15. Feraille E and Doucet A. Sodium-potassium adenosine triphosphatase-dependent sodium transport in the kidney: hormonal control. Physiol Rev 81: 345-418, 2001.
16. Fleming JW, Wisler PL, and Watanabe AM. Signal transduction by G proteins in cardiac tissues. Circulation 85: 420-433, 1995.
17. Ge C, Garcia R, and Anand-Srivastava MB. Altered expression of Gi-protein and adenylyl cyclase activity in hearts from one kidney one clip hypertensive rats: effect of captopril. JHypertens 17: 1617-1626, 1999.
18. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y, and Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A 96: 11507-11512, 1999.
19. Hattori R, Otani H, Maulik N, and Das DK. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol 282: H1988-H1995, 2002.
20. Hempel A, Noll T, Bach C, Piper HM, Willenbrock R, Hohnel K, Haller H, and Luft FC. Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability. Am J Physiol 275: H1818-H1825, 1998.
21. Hildebrandt JD, Hanoune J, and Birnbaumer L. Guanine nucleotide inhibition of cyc-S49 mouse lymphoma cell membrane adenylyl cyclase J Biol Chem 257: 14723-14725, 1982.
22. Imammura G, Bertelli AA, Bertelli A, Otani H, Maulik N, and Das DK. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 282: H1996-H2003, 2002.
23. Itoh H, Toyama R, Kozasa T, Tsukamoto T, Matsuoka M, and Kaziro Y. Presence of three distinct molecular species of Gi protein alpha subunit. Structure of rat cDNAs and human genomic DNAs. J Biol Chem 263: 6656-6664, 1988.
24. Jones DT and Reed R. Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. J Biol Chem 262: 14241-14249, 1987.
25. Katz AM, Tada M, and Kirshberger MA. Control of calcium transport in the myocardium by the cyclic AMP-protein kinase system. Adv Cyclic Nucleotide Res 5: 453-472, 1975.
26. Kinoshita S, Sidhu A, and Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from spontaneously hypertensive rats. J Clin Invest 84: 1849-1856, 1989.
27. Kumar KV and Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 19: 59-66, 1993.
28. Lacy F, O'Connor DT, and Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensive and normotensive subjects at genetic risk of hypertension. J Hypertens 16: 291-300, 1998.
29. G-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system. J Hypertens 16: 63-76, 1998.
30. Lane P and Gross SS. Cell signaling by nitric oxide. Semin Nephrol 19: 215-229, 1999.
31. Li Y and Anand-Srivastava MB. Inactivation of enhanced expression of Gi proteins by pertussis toxin attenuates the development of blood pressure in spontaneously hypertensive rats. Circ Res 91: 247-254, 2002.
32. Limas C and Limas CJ. Reduced number of β-adrenergic receptors in the myocardium of spontaneously hypertensive rats. Biochem Biophys Res Commun 83: 710-714, 1978.
33. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
34. Marcil J, Thibault C, and Anand-Srivastava MB. Enhanced expression of Gi-protein precedes the development of blood pressure in spontaneously hypertensive rats. J Mol Cell Cardiol 29: 1009-1022, 1997.
35. Marcil J, de Champlain J, and Anand-Srivastava MB. Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase. Cardiovasc Res 39: 492-505, 1998.
36. Murakami T and Yasuda H. Rat heart cell membranes contain three substrates for cholera toxin-catalyzed ADP-ribosylation and a single substrate for pertussis toxin-catalyzed ADP-ribosylation. Biochem Biophys Res Commun 138: 1355-1361, 1986.
37. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, and Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 88: 10045-10048, 1991.
38. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80: 249-257, 1995.
39. Noll T, Hempel A, and Piper NM. Neuropeptide Y reduces macromolecule permeability of coronary endothelial monolayers. Am J Physiol 271: H1878-H1883, 1996.
40. Palaparti A, Ge C, and Anand-Srivastava MB. Angiotensin II enhances the expression of Giα-2 in A10 cells (smooth muscle): relationship with adenylyl cyclase activity. Arch Biochem Biophys 365: 113-122, 1999.
41. Piacentini L, Wainwright CL, and Parratt JR. The antiarrhythmic effect of ischaemic preconditioning in isolated rat heart involves a pertussis toxin sensitive mechanism. Cardiovasc Res 27: 674-680, 1993.
42. Rees DD, Palmer RMJ, and Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A 86: 3375-3378, 1998.
43. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, and Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20: 298-303, 1992.
44. Robishaw JD, Smigel MD, and Gilman AG. Molecular basis for two forms of the G protein that stimulates adenylate cyclase. J Biol Chem 261: 9587-9590, 1986.
45. Salomon Y, Londos C, and Rodbell M. A highly sensitive adenylyl cyclase assay. Anal Biochem 58: 541-548, 1974.
46. Sambrook J, Fritisch EF, and Maniatis T. Labeling the 5′ terminus of DNA with bacteriophage T4 polynucleotide kinase. In: Molecular Cloning. A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989, pp. 10.59-10.61.
47. Taddei S, Virdis A, Ghiadoni L, Magagna A, and Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97: 2222-2229, 1998.
48. Thibault C and Anand-Srivastava MB. Altered expression of G-protein mRNA in spontaneously hypertensive rats. FEBS Lett 313: 160-164, 1992.
49. Triner L, Vulliemoz Y, Verosky M, Habif DU, and Nahas GG. Adenylyl cyclase-phosphodiesterase system in arterial smooth muscle. Life Sci 11: 817-824, 1972.
50. Tsuda K, Tsuda S, Nishio I, Goldstein M, and Masuyama Y. Modulation of [3H]dopamine release by neuropeptide Y in rat striatal slices. Eur J Pharmacol 321: 5-11, 1997.
51. Vanhoutte PM. Endothelium and control of vascular function. Hypertension 13: 658-667, 1989.
52. White CR, Brock TA, Chang LY, Crapo J, Brisco P, Ku D, Bradley WA, Gianturco SH, Gore J, and Freeman BA. Superoxide and peroxynitrite in atherosclerosis Proc Natl Acad Sci U S A 91: 1044-1048, 1994.
53. + channel is stimulated by three distinct Gi alpha-subunits. Nature 336: 680-682, 1988.
54. Zanchi A, Schad NC, Osterheld MC, Growzmann E, Nussberger J, Brunner HR, and Waeber B. Effect of NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Am J Physiol 37: H2267-H2273, 1995.